WALKER WAYNE REMELL 4

What Happened

• Walker Wayne Remell, a director of Petros Pharmaceuticals, was granted 375,000 restricted shares on 2026-06-05. The reported acquisition price is $0.00 (no cash paid) and the transaction is coded as an award/grant (A).

Key Details

• Transaction date: 2026-06-05; Form 4 filed: 2026-06-08.
• Transaction type/code: Award/Grant (A).
• Shares granted: 375,000 restricted common shares; reported cash paid: $0.00.
• Vesting: 50% vested on the grant date; remaining 50% vests on the six‑month anniversary, contingent on continued service (footnote F1).
• Shares owned after transaction: Not specified in the filing.
• Timeliness: Filing date (June 8) is within the SEC’s Form 4 reporting window (filed within the required business-day period).

Context

• These are restricted stock awards (compensation), not an open‑market purchase or sale. Restricted shares vest over time and may be subject to transfer restrictions and company insider trading policies. Awards to directors are common and reflect compensation rather than an immediate buy/sell trading signal.